Innate Pharma Ratios (2017-2025) | IPHA

Ratios Dec2017 Dec2018 Jun2019 Dec2019 Jun2020 Dec2020 Jun2021 Dec2021 Jun2022 Dec2022 Jun2023 Dec2023 Jun2024 Dec2024 Jun2025 Dec2025
Profitability
EBT Margin (Quarter) -1.48%-184.10%-0.10%1.61%-14.59%-298.61%-391.94%
EBIT Margin (Quarter) -13.52%-193.60%-0.11%-1.13%-18.12%-317.29%-423.44%
EBITDA Margin (Quarter) -13.52%-193.60%-0.11%-1.13%-18.12%-317.29%-423.44%
Operating Margin (Quarter) -193.60%-1.13%-317.29%
Net Margin (Quarter) -390.23%-464.60%-0.54%-93.89%1.61%-114.59%-298.61%-461.93%
FCF Margin (Quarter) -90.57%-232.88%3.13%-32.28%-31.56%-62.06%-51.54%
Efficiency
Assets Average (Quarter) 0.41B166.76B166.72B0.34B0.31B0.30B0.26B0.21B0.20B0.18B0.14B0.11B0.09B
Equity Average (Quarter) 0.15B104.00B103.97B0.17B0.14B0.12B0.09B0.06B0.06B0.04B0.02B0.01B-0.01B
Invested Capital (Quarter) 0.11B0.21B0.26B209.80B0.20B0.16B0.17B0.16B0.10B0.07B0.10B0.04B0.04B0.02B0.00B
Asset Utilization Ratio (Quarter) 0.050.900.900.920.83
Leverage & Solvency
Interest Coverage Ratio (Quarter) 5.171.881.1211.9711.890.415.1312.7513.459.0716.76
Debt to Equity (Quarter) 0.070.030.090.090.120.120.410.370.780.700.771.233.515.25-1.04
Debt Ratio (Quarter) 0.020.010.050.060.060.060.170.150.200.200.230.230.280.290.36
Equity Ratio (Quarter) 0.340.370.540.620.510.500.400.410.260.290.300.190.080.06-0.35
Times Interest Earned (Quarter) 5.171.881.1211.9711.890.415.1312.7513.459.0716.76
Valuation
Enterprise Value (Quarter) -0.14B-0.19B-0.17B-0.24B-147.74B-0.18B-0.18B-0.14B-0.13B-0.10B-0.11B-0.10B-0.10B-0.09B-0.08B-0.04B
Return Ratios
Return on Sales (Quarter) -0.01%0.00%0.00%0.00%0.00%0.00%-0.03%-0.04%
Return on Capital Employed (Quarter) -13.42%-29.49%-26.37%-27.50%-40.84%-28.93%-90.85%-158.15%-377.03%
Return on Assets (Quarter) 0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%-0.01%-0.01%-0.01%
Return on Equity (Quarter) 0.00%0.00%-0.01%-0.01%-0.01%0.00%0.00%0.00%-0.01%-0.04%-0.15%0.11%